AmeriPath Credit Set To Hit Market

  • 23 Feb 2003
Email a colleague
Request a PDF

Credit Suisse First Boston and Deutsche Bank are launching this Wednesday a $365 million deal backing plans by Amy Acquisition Corp.-- a Welsh, Carson, Anderson & Stowe company-- to acquire cancer diagnostics provider AmeriPath. The bank duo will be shopping a $290 million "B" piece at LIBOR plus 33/4% and a $75 million revolver. Pricing on the revolver could not be ascertained. The transaction is valued at $839.4 million, including AmeriPath's 2002 debt and an estimated $65.1 million in assumed contingent obligations (LMW, 12/16). CSFB and Deutsche Bank bankers did not return calls.

Riviera Beach, Fla.-based AmeriPath will release its 2002 fourth quarter and year-end financial results tomorrow. There were reports that results fell below investor expectations. James New, ceo of AmeriPath, further acknowledged in a company report that the fourth quarter results were below company targets. He noted, however, that AmeriPath's "cash collections in the fourth quarter and for the year were [still] strong." Welsh Carson and the company expect the transaction to close before April 30 of this year. An AmeriPath spokeswoman did not return calls, while a Welsh Carson official declined to comment.

  • 23 Feb 2003

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 14,443 29 18.07
2 Bank of America Merrill Lynch (BAML) 8,264 27 10.34
3 Lloyds Bank 7,329 24 9.17
4 Citi 6,748 19 8.44
5 JP Morgan 5,220 8 6.53

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 117,261.12 337 11.07%
2 Bank of America Merrill Lynch 94,721.79 272 8.94%
3 JPMorgan 92,612.23 269 8.74%
4 Wells Fargo Securities 82,597.19 239 7.80%
5 Credit Suisse 69,442.99 183 6.55%